↓ Skip to main content

Long-Term Cholinesterase Inhibitor Treatment of Alzheimer’s Disease

Overview of attention for article published in CNS Drugs, August 2012
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (67th percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
1 X user
patent
7 patents

Citations

dimensions_citation
50 Dimensions

Readers on

mendeley
62 Mendeley
Title
Long-Term Cholinesterase Inhibitor Treatment of Alzheimer’s Disease
Published in
CNS Drugs, August 2012
DOI 10.2165/00023210-200418120-00001
Pubmed ID
Authors

Peter Johannsen

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 62 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 2%
United States 1 2%
Unknown 60 97%

Demographic breakdown

Readers by professional status Count As %
Student > Master 9 15%
Student > Ph. D. Student 8 13%
Professor 6 10%
Researcher 5 8%
Professor > Associate Professor 4 6%
Other 13 21%
Unknown 17 27%
Readers by discipline Count As %
Medicine and Dentistry 15 24%
Psychology 7 11%
Agricultural and Biological Sciences 4 6%
Pharmacology, Toxicology and Pharmaceutical Science 4 6%
Biochemistry, Genetics and Molecular Biology 3 5%
Other 8 13%
Unknown 21 34%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 26 October 2020.
All research outputs
#7,959,659
of 25,371,288 outputs
Outputs from CNS Drugs
#721
of 1,387 outputs
Outputs of similar age
#58,253
of 187,944 outputs
Outputs of similar age from CNS Drugs
#253
of 540 outputs
Altmetric has tracked 25,371,288 research outputs across all sources so far. This one has received more attention than most of these and is in the 67th percentile.
So far Altmetric has tracked 1,387 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.6. This one is in the 46th percentile – i.e., 46% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 187,944 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 67% of its contemporaries.
We're also able to compare this research output to 540 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 50% of its contemporaries.